Type 2 diabetes
BACKGROUND – THE STUDY QUESTIONBackground • In type 2 diabetes, the body’s cells is resistance to insulin which results in excess blood sugar.• Canagliflozin inhibits sodium-glucose cotransporter-2.• the kidney-based inhibition reduces the rate at which glucose is reabsorbed. The latter results in increased glucose excretion via urine and reduced plasma glucose.• The drug is indicated […]